Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Chang

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Harm Reduction Journal|February 14, 2023
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service deliveryGraham Shaw, Robin Schaefer, Heather-Marie A Schmidt, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore proteinKumar Visvanathan, Narelle A Skinner, Alex J V Thompson, et al.
The Journal of Infectious Diseases|February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapyMegan Crane, Ben Oliver, Gail Matthews, et al.
Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Cannabis and Nicotine Substance Use Coercion During the Perinatal PeriodPeyton Groves, Callie Laubacher, Yesmina Salib, et al.
Journal of Psychiatric Research|December 27, 2016
Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparisonJung-Yoon Heo, Kiwon Kim, Maurizio Fava, et al.
Journal of the International AIDS Society|July 20, 2019
Partner Notification: A Community ViewpointGeorge Ayala, Mahri Bahati, Elie Balan, et al.
The Lancet. HIV|April 13, 2018
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trialThomas A Rasmussen, James H McMahon, J Judy Chang, et al.
Ebiomedicine|November 13, 2025
Pomalidomide enhances CD8<sup>+</sup> T and NK cell mediated killing of HIV-infected cellsRachel D Pascoe, Celine Gubser, J Judy Chang, et al.
Journal of Virus Eradication|September 27, 2023
Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trialMatthew C Pitman, Niamh Meagher, David J Price, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Harm Reduction Journal|February 14, 2023
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service deliveryGraham Shaw, Robin Schaefer, Heather-Marie A Schmidt, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore proteinKumar Visvanathan, Narelle A Skinner, Alex J V Thompson, et al.
The Journal of Infectious Diseases|February 24, 2009
Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapyMegan Crane, Ben Oliver, Gail Matthews, et al.
Journal of Virology|January 8, 2010
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapyMegan Crane, Sunee Sirivichayakul, J Judy Chang, et al.
Women'S Health Reports (New Rochelle, N.Y.)|October 27, 2025
Cannabis and Nicotine Substance Use Coercion During the Perinatal PeriodPeyton Groves, Callie Laubacher, Yesmina Salib, et al.
Journal of Psychiatric Research|December 27, 2016
Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparisonJung-Yoon Heo, Kiwon Kim, Maurizio Fava, et al.
Journal of the International AIDS Society|July 20, 2019
Partner Notification: A Community ViewpointGeorge Ayala, Mahri Bahati, Elie Balan, et al.
The Lancet. HIV|April 13, 2018
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trialThomas A Rasmussen, James H McMahon, J Judy Chang, et al.
Ebiomedicine|November 13, 2025
Pomalidomide enhances CD8<sup>+</sup> T and NK cell mediated killing of HIV-infected cellsRachel D Pascoe, Celine Gubser, J Judy Chang, et al.
Journal of Virus Eradication|September 27, 2023
Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trialMatthew C Pitman, Niamh Meagher, David J Price, et al.
Pageof 8